VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,875 | -32.3% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $5,725 | +48.5% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $3,855 | +26.4% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $3,050 | +1.7% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | +300.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -85.7% | 500 | -80.0% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 2,500 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | -25.0% | 2,500 | +8.7% | 0.00% | – |
| Q4 2020 | $16,000 | -36.0% | 2,300 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $25,000 | -13.8% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $29,000 | +38.1% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $21,000 | -34.4% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $32,000 | -20.0% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $40,000 | -36.5% | 2,300 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $63,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |